Trial Profile
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Velneperit (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Shionogi USA
- 26 Mar 2010 Actual patient number (766) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Actual end date (March 2010) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.